StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

Coya Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Coya Therapeutics's price to book ratio was 1.7× on Nov 11, 2026, against 4.0× a year earlier. Over the last 4 years it ranged from 1.7× to 7.3×, with a median of 2.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−1.8
2025Dec 31, 20253.6×+0.8
2024Dec 31, 20242.7×−4.6
2023Dec 29, 20237.3×+3.9
2022Dec 30, 20223.4×–

More Coya Therapeutics figures

See a number that looks wrong?